RARE Ultragenyx Pharmaceutical Inc.

RARE Ultragenyx Pharmaceutical Inc.

Healthcare · Biotechnology

Market read

Scan convergence 2 scans as of 2026-10-23 1 bear 1 neutral converging

POC $14.43 · VWAP $22.61 · -30.8% vs 12m avg buyer

collapse vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CFO, EVP sold $164.4K, Aug 4

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

RARE Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist RARE belongs to, members best 30-day change first — RARE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
View watchlist →
PACB+49.6% +2.4%1d +22.0%7d ICLR+13.0% -0.1%1d +8.9%7d BIIB+10.2% -1.2%1d +7.8%7d MRNA+9.9% -1.3%1d -8.2%7d MEDP+8.4% +2.3%1d +8.2%7d AMGN+8.2% -1.8%1d +1.6%7d ILMN+5.5% 0.0%1d +2.6%7d RARE+5.2% -1.9%1d +7.6%7d LEGN+4.4% +2.0%1d +4.3%7d NTRA+3.4% +0.6%1d +2.7%7d GILD+3.1% -0.7%1d -0.1%7d VRTX+1.5% -2.1%1d +4.8%7d REGN+0.4% -1.7%1d +1.8%7d PTGX-0.2% -0.8%1d +7.5%7d COGT-0.6% -0.3%1d +5.7%7d BEAM-1.3% -2.1%1d +2.5%7d RVMD-2.0% -0.4%1d +5.1%7d IONS-2.3% -2.2%1d 0.0%7d ABCL-4.0% +4.0%1d +0.2%7d KYMR-4.1% -0.1%1d +5.7%7d IBRX-4.8% -1.1%1d -10.5%7d TXG-5.4% +2.6%1d +2.4%7d ABSI-5.8% -2.0%1d +11.3%7d SRPT-6.4% -2.5%1d +3.7%7d INCY-7.2% -1.0%1d +2.3%7d ARGX-7.6% -0.2%1d +6.7%7d NTLA-9.1% +0.5%1d -1.8%7d ALNY-9.1% -1.4%1d -3.4%7d QTRX-9.5% +0.7%1d -0.3%7d BMRNE-10.1% -1.2%1d +2.3%7d BNTX-10.5% -1.7%1d +0.5%7d EDIT-10.8% -3.6%1d +2.1%7d CRSP-11.4% -1.2%1d +0.3%7d TWST-11.7% +3.3%1d +5.4%7d TEM-11.7% +6.0%1d +4.5%7d SDGR-18.6% +5.3%1d +5.3%7d NKTR-35.5% -3.7%1d +4.0%7d
@biotech-scan
View watchlist →
GRAL+22.1% +4.3%1d +12.5%7d DNA+16.4% +2.9%1d -2.7%7d ISRG+13.6% +1.9%1d +6.0%7d LLY+10.6% -2.5%1d +1.3%7d BIIB+10.2% -1.2%1d +7.8%7d MRNA+9.9% -1.3%1d -8.2%7d AMGN+8.2% -1.8%1d +1.6%7d ABBV+7.8% +0.2%1d +0.1%7d MDT+6.8% -1.2%1d +0.7%7d ILMN+5.5% 0.0%1d +2.6%7d RARE+5.2% -1.9%1d +7.6%7d A+4.7% -0.5%1d +0.1%7d LEGN+4.4% +2.0%1d +4.3%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d GILD+3.1% -0.7%1d -0.1%7d NVO+2.3% -1.0%1d +0.6%7d VRTX+1.5% -2.1%1d +4.8%7d TMO+1.3% -0.4%1d -2.3%7d IBB+0.6% -0.9%1d +2.9%7d REGN+0.4% -1.7%1d +1.8%7d RXRX0.0% +3.4%1d +6.6%7d PTGX-0.2% -0.8%1d +7.5%7d COGT-0.6% -0.3%1d +5.7%7d IBBQ-0.7% -1.1%1d +2.4%7d BEAM-1.3% -2.1%1d +2.5%7d IONS-2.3% -2.2%1d 0.0%7d XBI-3.6% -1.4%1d +3.6%7d KYMR-4.1% -0.1%1d +5.7%7d DFTX-5.3% -0.9%1d +11.1%7d SRPT-6.4% -2.5%1d +3.7%7d INCY-7.2% -1.0%1d +2.3%7d NTLA-9.1% +0.5%1d -1.8%7d ALNY-9.1% -1.4%1d -3.4%7d BMRNE-10.1% -1.2%1d +2.3%7d BNTX-10.5% -1.7%1d +0.5%7d EDIT-10.8% -3.6%1d +2.1%7d DXCM-11.2% -0.5%1d -9.4%7d CRSP-11.4% -1.2%1d +0.3%7d IMVT-17.8% -2.4%1d +6.3%7d NKTR-35.5% -3.7%1d +4.0%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jul 2 pass n/a Watched, not owned -27.0% complete

Next earnings RARE reports in 11 days Nov 3

Last report Aug 4

Reported the quarter ending 2026-06-30: revenue $214M, diluted EPS -$0.90, net income -$92M (SEC filing). Across the print the stock moved -0.4% (close before → first close after).

full note →

Against street estimates

How RARE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Oct 23

Result
Aug 4 -1.00-0.90+9.7%Beat
May 5 -1.46-1.54-5.7%Miss
Feb 12 -1.17-1.29-10.1%Miss
Nov 4 '25 -1.21-1.81-49.7%Miss
Aug 5 '25 -1.32-1.17+11.4%Beat
May 6 '25 -1.64-1.57+4.4%Beat
Feb 13 '25 -1.27-1.39-9.4%Miss
Nov 5 '24 -1.47-1.40+5.0%Beat

News (last pull)

Headlines about RARE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 35 days ago · Sep 18

RARE research tape

41 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Washout-Turn Scan — 2026-10-23 scan Washout-Turn Scan — 2026-10-22 scan Washout-Turn Scan — 2026-10-21 scan Biotech Scan — October 16, 2026 scan Biotech Scan — October 9, 2026
Types
Oct 23 Scan Washout Turn Scan
300124.SZ300748.SZADBEARESBAHEBRBRCOMPDPZ +4 more
Oct 22 Scan Washout Turn Scan
603728.SSADMABAHEBRBRDOWDPZDUSTEIX +4 more
Oct 21 Scan Washout Turn Scan
603728.SSADBEADMAASBRBRCASYCECHKP +4 more
Oct 16 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNENVOIMVTIONSINCYALNYREGN +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 17 Market Brief The Session After the Hike Was the Broadest Up Day of the Month
AAUCABCLACGLALLYALSNARWRSDGRGNRC +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 3 Market Brief Software Re-Rates, Semis Stay Home
AAPLABBNYALMSARBGBNORAREMSTR +4 more
Sep 3 Article Ultragenyx Phase 3 Aspire misses in Angelman syndrome — article
RARE
Sep 2 Scan Washout Turn Scan
AAAAUCACNAIALBALNYALTARMP +4 more
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 4 Catalyst RARE earnings
RARE
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 25 Scan Biotech Scan
CRSPBEAMNTLAALNYLEGNMRNABNTXLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNEBNTX +4 more
May 5 Catalyst RARE earnings
RARE
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNEBNTXCRSPDHR +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNEBNTXDHR +4 more